Three high risk indicators that aid mammography screening

Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.

The importance of relying on more than one high risk model has been outlined by the National Cancer Institute. They say that the Gail model alone significantly underestimates breast cancer risk for women with genetic susceptibility. That's why MRS is leading the way in high risk evaluation. Our reporting system is the only one in the industry that includes three high risk indicators: the results of Gail model calculations, the NCI model calculations, and a model that indicates if a patient is at high risk based on genetic factors.

In MRS, if a patient's demographic history indicates the potential of an inherited risk for breast cancer, it will alert the radiologist that the patient could benefit from increased surveillance or genetic testing. That genetic testing would identify a patient with the BRCA1 or BRCA2 mutation. Those genes are known as tumor suppressors and have been linked to both hereditary breast and ovarian cancer.

MRS's three high risk indicators are changing the landscape in mammography screening. It gives radiologists a better indication when an MRI may be necessary, or other pre-emptive breast care to help patients earlier than ever before.

SOURCE Mammography Reporting System, Inc. (MRS)